[Federal Register Volume 86, Number 164 (Friday, August 27, 2021)]
[Notices]
[Page 48230]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-18505]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Center for Advancing Translational Sciences; Notice of 
Closed Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended, notice is hereby given of the following meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the cooperative agreement applications, the disclosure 
of which would constitute a clearly unwarranted invasion of personal 
privacy.

    Name of Committee: National Center for Advancing Translational 
Sciences Special Emphasis Panel; RFA-TR-21-009: Screening for 
Conditions by Electronic Nose Technology (SCENT).
    Date: September 28, 2021.
    Time: 10:00 a.m. to 6:00 p.m.
    Agenda: To review and evaluate cooperative agreement 
applications.
    Place: National Center for Advancing Translational Sciences, 
National Institutes of Health, 6701 Democracy Boulevard, Room 1078, 
Bethesda, MD 20892 (Virtual Meeting).
    Contact Person: Rahat (Rani) Khan, Ph.D., Scientific Review 
Officer, Office of Grants Management and Scientific Review, National 
Center for Advancing Translational Sciences, National Institutes of 
Health, 6701 Democracy Boulevard, Room 1078, Bethesda, MD 20892, 
301-894-7319, <a href="/cdn-cgi/l/email-protection#fa91929b9488c8ba998988d4949392d49d958c"><span class="__cf_email__" data-cfemail="92f9faf3fce0a0d2f1e1e0bcfcfbfabcf5fde4">[email protected]</span></a>.

    Name of Committee: National Center for Advancing Translational 
Sciences Special Emphasis Panel; National Center for Advancing 
Translational Sciences Special Emphasis Panel.
    Date: September 30, 2021
    Time: 11:00 a.m. to 3:00 p.m.
    Agenda: To review and evaluate cooperative agreement 
applications.
    Place: National Center for Advancing Translational Sciences, 
National Institutes of Health, 6701 Democracy Boulevard, Room 1078, 
Bethesda, MD 20892 (Virtual Meeting).
    Contact Person: Alumit Ishai, Ph.D., Scientific Review Officer, 
Office of Grants Management and Scientific Review, National Center 
for Advancing Translational Sciences, National Institutes of Health, 
6701 Democracy Boulevard, Suite 1000, Bethesda, MD 20892, 301-827-
5819, <a href="/cdn-cgi/l/email-protection#95f4f9e0f8fce1bbfce6fdf4fcd5fbfcfdbbf2fae3"><span class="__cf_email__" data-cfemail="60010c150d09144e0913080109200e09084e070f16">[email protected]</span></a>.

(Catalogue of Federal Domestic Assistance Program Nos. 93.859, 
Pharmacology, Physiology, and Biological Chemistry Research; 93.350, 
B--Cooperative Agreements; 93.859, Biomedical Research and Research 
Training, National Institutes of Health, HHS)

    Dated: August 23, 2021.
David W. Freeman,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2021-18505 Filed 8-26-21; 8:45 am]
BILLING CODE 4140-01-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>